Johnson Matthey Health Rebrands as Veranova
Following the acquisition by Altaris Capital Partners, Johnson Matthey Health has rebranded as Veranova.
Veranova, a contract manufacturing and development organization focusing on APIs, announced its launch as an independent company on June 1, 2022. Formerly known as Johnson Matthey Health, Veranova has rebranded itself following its acquisition by Altaris Capital Partners.
According to a company press release, the new name originates from the Latin words ‘vērus’ meaning ‘true’ and ‘nŏvus’ meaning ‘new’, representing the reliability and innovative approach of the company respectively. Veranova currently holds over 425 active patents and over the course of the past century has helped develop more than 100 APIs, including the first platinum-based drugs for cancer treatment.
Veranova is headquartered in Wayne, PA, with manufacturing operations in West Deptford, NJ; Devens, MA; North Andover, MA; Annan, UK; and Edinburgh, UK. The company also has manufacturing and R&D centers in Cambridge, UK, and Yantai, China.
Source: Veranova
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
In Wake of Trump Tariffs, Lilly Plans New US Pharmaceutical Manufacturing Sites
February 26th 2025Previous domestic capital expansion commitments since 2020 had been made in Research Triangle Park and Concord, both in North Carolina; Kenosha County, Wisconsin; Lebanon, Indiana; and Lilly’s home city of Indianapolis.
